[On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010489:Periarthritis / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012585:Sciatica / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D007213:Indomethacin
Sull'impiego in terapia antireumatica di un nuovo antiflogistico non steroideeo: la glucosamide dell'acido (n-p.clorobenzoil-2metil-5-metossi)-indol-3-acetico monoidrato.